10x Genomics strikes back in Bio-Rad saga with USITC ban
13-02-2020
Bill Perry / Shutterstock.com
The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bio-Rad, 10X Genomics, Federal Circuit, labs-on-a-chip, damages, patent infringement, Delaware, district court, appeal
